entity

IMMUNE_TOL

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about IMMUNE_TOL: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
0Hypotheses
0Analyses
0Outgoing
1Incoming

Wiki Pages (20)

Knowledge base pages for this entity

Benfotiamine Phase 2 Alzheimer's Disease Trial (NCT06223360)

clinical · 3941 words

Methylphenidate + iTBS for Apathy in AD (PRIME Trial)

clinical · 3302 words

Experiment: Autoimmune Hypothesis Testing in AD

experiment · 2980 words

AMDX-2011P Retinal Amyloid Tracer in Alzheimer's Disease

clinical · 2654 words

MK-1167 Phase 2 Alzheimer's Disease Trial

clinical · 1969 words

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (1)

SourceRelationTypeStr
ADcausesdisease0.72

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found